Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.

OBJECTIVES: Functional (psychogenic or somatoform) symptoms are common in neurology clinics. Cognitive-behavioral therapy (CBT) can be an effective treatment, but there are major obstacles to its provision in practice. We tested the hypothesis that adding CBT-based guided self-help (GSH) to the usua...

Full description

Bibliographic Details
Main Authors: Sharpe, M, Walker, J, Williams, C, Stone, J, Cavanagh, J, Murray, G, Butcher, I, Duncan, R, Smith, S, Carson, A
Format: Journal article
Language:English
Published: 2011
_version_ 1797105172354170880
author Sharpe, M
Walker, J
Williams, C
Stone, J
Cavanagh, J
Murray, G
Butcher, I
Duncan, R
Smith, S
Carson, A
author_facet Sharpe, M
Walker, J
Williams, C
Stone, J
Cavanagh, J
Murray, G
Butcher, I
Duncan, R
Smith, S
Carson, A
author_sort Sharpe, M
collection OXFORD
description OBJECTIVES: Functional (psychogenic or somatoform) symptoms are common in neurology clinics. Cognitive-behavioral therapy (CBT) can be an effective treatment, but there are major obstacles to its provision in practice. We tested the hypothesis that adding CBT-based guided self-help (GSH) to the usual care (UC) received by patients improves outcomes. METHODS: We conducted a randomized trial in 2 neurology services in the United Kingdom. Outpatients with functional symptoms (rated by the neurologist as "not at all" or only "somewhat" explained by organic disease) were randomly allocated to UC or UC plus GSH. GSH comprised a self-help manual and 4 half-hour guidance sessions. The primary outcome was self-rated health on a 5-point clinical global improvement scale (CGI) at 3 months. Secondary outcomes were measured at 3 and 6 months. RESULTS: In this trial, 127 participants were enrolled, and primary outcome data were collected for 125. Participants allocated to GSH reported greater improvement on the primary outcome (adjusted common odds ratio on the CGI 2.36 [95% confidence interval 1.17-4.74; p = 0.016]). The absolute difference in proportion "better" or "much better" was 13% (number needed to treat was 8). At 6 months the treatment effect was no longer statistically significant on the CGI but was apparent in symptom improvement and in physical functioning. CONCLUSIONS: CBT-based GSH is feasible to implement and efficacious. Further evaluation is indicated. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CBT-based GSH therapy improves self-reported general health, as measured by the CGI, in patients with functional neurologic symptoms.
first_indexed 2024-03-07T06:43:40Z
format Journal article
id oxford-uuid:fa2560d1-07b1-49e5-a859-c35ca2d2ebf2
institution University of Oxford
language English
last_indexed 2024-03-07T06:43:40Z
publishDate 2011
record_format dspace
spelling oxford-uuid:fa2560d1-07b1-49e5-a859-c35ca2d2ebf22022-03-27T13:03:27ZGuided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fa2560d1-07b1-49e5-a859-c35ca2d2ebf2EnglishSymplectic Elements at Oxford2011Sharpe, MWalker, JWilliams, CStone, JCavanagh, JMurray, GButcher, IDuncan, RSmith, SCarson, AOBJECTIVES: Functional (psychogenic or somatoform) symptoms are common in neurology clinics. Cognitive-behavioral therapy (CBT) can be an effective treatment, but there are major obstacles to its provision in practice. We tested the hypothesis that adding CBT-based guided self-help (GSH) to the usual care (UC) received by patients improves outcomes. METHODS: We conducted a randomized trial in 2 neurology services in the United Kingdom. Outpatients with functional symptoms (rated by the neurologist as "not at all" or only "somewhat" explained by organic disease) were randomly allocated to UC or UC plus GSH. GSH comprised a self-help manual and 4 half-hour guidance sessions. The primary outcome was self-rated health on a 5-point clinical global improvement scale (CGI) at 3 months. Secondary outcomes were measured at 3 and 6 months. RESULTS: In this trial, 127 participants were enrolled, and primary outcome data were collected for 125. Participants allocated to GSH reported greater improvement on the primary outcome (adjusted common odds ratio on the CGI 2.36 [95% confidence interval 1.17-4.74; p = 0.016]). The absolute difference in proportion "better" or "much better" was 13% (number needed to treat was 8). At 6 months the treatment effect was no longer statistically significant on the CGI but was apparent in symptom improvement and in physical functioning. CONCLUSIONS: CBT-based GSH is feasible to implement and efficacious. Further evaluation is indicated. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that CBT-based GSH therapy improves self-reported general health, as measured by the CGI, in patients with functional neurologic symptoms.
spellingShingle Sharpe, M
Walker, J
Williams, C
Stone, J
Cavanagh, J
Murray, G
Butcher, I
Duncan, R
Smith, S
Carson, A
Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title_full Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title_fullStr Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title_full_unstemmed Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title_short Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial.
title_sort guided self help for functional psychogenic symptoms a randomized controlled efficacy trial
work_keys_str_mv AT sharpem guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT walkerj guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT williamsc guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT stonej guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT cavanaghj guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT murrayg guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT butcheri guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT duncanr guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT smiths guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial
AT carsona guidedselfhelpforfunctionalpsychogenicsymptomsarandomizedcontrolledefficacytrial